Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Immunological Checkpoint Inhibitors of HIV-infected Subjects With Cancer

NCT03767465 is registered in ClinicalTrials.gov with IrsiCaixa as lead sponsor.

NCT NCT03767465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03767465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Immunological Checkpoint Inhibitors of HIV-infected Subjects With Cancer
Lead sponsor
IrsiCaixa
Phase
Observational
Overall status
Completed
Start date
October 26, 2018
Completion date
October 11, 2019
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, hiv infection